EI
DGX icon

Ethic Inc’s Quest Diagnostics DGX Stock Holding History

Ethic Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.62M Buy
31,253
+6,593
+27% +$1.29M 0.08% 241
2026
Q1 		$4.83M Buy
24,660
+4,269
+21% +$829K 0.08% 265
2025
Q4 		$3.54M Buy
20,391
+5,967
+41% +$1.09M 0.05% 333
2025
Q3 		$2.75M Buy
14,424
+8,518
+144% +$1.51M 0.05% 386
2025
Q2 		$1.05M Sell
5,906
-38
-0.6% -$6.6K 0.02% 606
2025
Q1 		$1.01M Sell
5,944
-4,108
-41% -$675K 0.02% 598
2024
Q4 		$1.52M Buy
10,052
+2,829
+39% +$440K 0.03% 487
2024
Q3 		$961K Sell
7,223
-726
-9% -$108K 0.02% 581
2024
Q2 		$1.09M Buy
7,949
+726
+10% +$99.4K 0.03% 540
2024
Q1 		$961K Sell
7,223
-55
-0.8% -$7.14K 0.02% 581
2023
Q4 		$1M Buy
7,278
+4,023
+124% +$529K 0.03% 537
2023
Q3 		$397K Sell
3,255
-25
-0.8% -$3.33K 0.01% 744
2023
Q2 		$461K Sell
3,280
-605
-16% -$83.4K 0.02% 679
2023
Q1 		$550K Buy
3,885
+18
+0.5% +$2.58K 0.02% 624
2022
Q4 		$605K Buy
3,867
+1,792
+86% +$258K 0.03% 513
2022
Q3 		$255K Sell
2,075
-1,469
-41% -$193K 0.02% 683
2022
Q2 		$471K Buy
3,544
+189
+6% +$25.8K 0.03% 487
2022
Q1 		$459K Buy
+3,355
New +$468K 0.03% 485
2020
Q2 		– Sell
-2,665
Closed -$214K – 278
2020
Q1 		$214K Sell
2,665
-105
-4% -$10.9K 0.18% 173
2019
Q4 		$296K Buy
+2,770
New +$289K 0.22% 157

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return

Ethic Inc's DGX Position: Q2 2026 in Review

Ethic Inc increased its Quest Diagnostics (DGX) stake by 27% in Q2 2026, buying an estimated $1.29M and bringing the position to 31,253 shares worth $6.62M. The position accounts for 0.08% of the portfolio, ranked #241.

Ethic Inc first reported a position in DGX in Q4 2019 and has held it in 20 quarters since. 380 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Ethic Inc held 31,253 shares of Quest Diagnostics worth $6.62M as of Q2 2026.
  • Ethic Inc bought 6,593 Quest Diagnostics shares in Q2 2026, an estimated $1.29M.
  • Quest Diagnostics made up 0.08% of Ethic Inc's portfolio in Q2 2026, its #241 holding.
  • Ethic Inc first reported a position in Quest Diagnostics in Q4 2019 and has held it in 20 quarters since.
  • 380 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.